Using a Surgical PSA-Threshold (> 0.2 ng/mL) to Define Biochemical Failure in the ASCENDE-RT Phase 3 Trial

Publication date: May–June 2017
Source:Brachytherapy, Volume 16, Issue 3, Supplement
Author(s): William J. Morris, Mira Keyes, Tom Pickles




http://ift.tt/2pjHcMW